Abeona Therapeutics (ABEO) Preferred Dividend Payments (2011 - 2022)
Abeona Therapeutics' (ABEO) quarterly Preferred Dividend Payments came in at $3.8 million in Q2 2022, up 452.92% quarter-over-quarter from $684000.0 in Q4 2014.
Abeona Therapeutics (ABEO) Preferred Dividend Payments (2011 - 2022) Analysis & Trends
Abeona Therapeutics' Preferred Dividend Payments history runs 5 years deep, the most recent figure standing at $3.8 million for Q2 2022.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $3.8 million in Q2 2022; TTM through Dec 2022 was $3.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$20.3 million, changed N/A from the prior year.
- Preferred Dividend Payments climbed to $3.8 million in Q2 2022 per ABEO's latest filing, from $684000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $3.8 million in Q2 2022 and bottomed at $3.8 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 3.78 Mn |
| Dec 31, 2014 | 684,000.00 |
| Sep 30, 2014 | 740,000.00 |
| Jun 30, 2014 | 726,000.00 |
| Mar 31, 2014 | 725,000.00 |
| Dec 31, 2013 | 696,000.00 |
| Sep 30, 2013 | 742,000.00 |
| Jun 30, 2013 | 733,000.00 |
| Mar 31, 2013 | 727,000.00 |
| Dec 31, 2012 | 676,000.00 |
| Sep 30, 2012 | 444,000.00 |
| Jun 30, 2012 | 439,000.00 |
| Mar 31, 2012 | 440,000.00 |
| Dec 31, 2011 | 447,000.00 |
| Sep 30, 2011 | 447,000.00 |
| Jun 30, 2011 | 442,000.00 |
| Mar 31, 2011 | 438,000.00 |